𝔖 Bobbio Scriptorium
✦   LIBER   ✦

QUALIDEM: development and evaluation of a dementia specific quality of life instrument––validation

✍ Scribed by Teake P. Ettema; Rose-Marie Dröes; Jacomine de Lange; Gideon J. Mellenbergh; Miel W. Ribbe

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
103 KB
Volume
22
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Objective

To validate the QUALIDEM, a quality of life measure for people with dementia within residential settings rated by professional caregivers.

Method

In a sample of 202 residents of nursing homes Spearman rank correlations were calculated between the QUALIDEM subscales aand indices of convergent validity and discriminant validity, with dementia severity and need of care, with global QOL scores by the head nurse and family, and with self‐report on COOP/WONCA Charts.

Results

The one‐method multi‐trait matrix showed 90.5% of the correlations to be in support for convergent and discriminant validity. Low to moderate correlations were observed with dementia severity and need of care, confirming that QOL is not merely disease severity. Support for concurrent validity was found in correlations with QOL ratings by the head nurse. The QUALIDEM did not correlate with most of the family ratings or with the COOP/WONCA Charts.

Conclusion

The results of this validation study together with the obtained content validity through the method of construction provide sufficient support for validity of the QUALIDEM to be used for care evaluation and research in residential settings. Copyright © 2006 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

QUALIDEM: development and evaluation of
QUALIDEM: development and evaluation of a dementia specific quality of life instrument. Scalability, reliability and internal structure
✍ Teake P. Ettema; Rose-Marie Dröes; Jacomine de Lange; Gideon J. Mellenbergh; Mie 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## Abstract ## Objective To develop a Quality of Life questionnaire rated by professionals that can be used for people with dementia in different stages of the disease, living in residential settings. ## Method Development was performed in two phases: item generation and pilot testing, and a fie

Evaluation of Qualidem: a dementia-speci
Evaluation of Qualidem: a dementia-specific quality of life instrument for persons with dementia in residential settings; scalability and reliability of subscales in four Dutch field surveys
✍ A. I. E. Bouman; T. P. Ettema; R. B. Wetzels; A. P. A. van Beek; J. de Lange; R. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract ## Objective To evaluate the scalability and reliability of Qualidem, a quality of life observation instrument rated by professional caregivers of persons with mild to very severe dementia living in residential settings. ## Method Data from four field surveys in the Netherlands were

Validation of a disease-specific quality
Validation of a disease-specific quality-of-life instrument for acoustic neuroma : The Penn Acoustic Neuroma Quality-of-Life Scale
✍ Brian T. Shaffer; Michael S. Cohen; Douglas C. Bigelow; Michael J. Ruckenstein 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB

## Abstract ## Objectives/Hypothesis: To design and validate the first disease‐specific quality‐of‐life instrument for acoustic neuroma, the Penn Acoustic Neuroma Quality‐of‐Life (PANQOL) scale. ## Study Design: Prospective instrument validation. ## Methods: One hundred forty‐three patients wi

Development and validation of a disease-
Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: The hepatitis B quality of life instrument, version 1.0
✍ Brennan M. R. Spiegel; Roger Bolus; Steven Han; Myron Tong; Eric Esrailian; Jenn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

Despite the increasing realization that health-related quality of life (HRQOL) is an important outcome in chronic HBV infection, there are no validated, disease-targeted instruments currently available. We sought to develop and validate the first disease-targeted HRQOL instrument in noncirrhotic HBV